NCT00360074
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dyslipidemias, +12 more
- Locations
-
- University Hospital Freiburg, Department of Medicine Freiburg im Breisgau, Baden-Wurttemberg, Germany
Clinical trial condition
Hyperlipidemias
Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.
685 public trials
58 recruiting studies
Hyperlipidemias trial results
NCT00654459
- Conditions
- Dyslipidemias, Endothelial Dysfunction, Hyperlipidemia, +4 more
- Locations
-
- Department of internal medicine University Federico II Naples, Italy
NCT00039663
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Blood-Borne Infections, +31 more
- Locations
-
- National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States
NCT00080587
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00001142
- Conditions
- Blood-Borne Infections, Communicable Diseases, Disease Attributes, +29 more
- Locations
-
- National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States
NCT00222833
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemias, +15 more
- Locations
-
- Western Psychiatric Institute and Clinic of UPMC Pittsburgh, Pennsylvania, United States
NCT00287404
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +7 more
- Locations
-
- University of North Carolina Diabetes Care Center Durham, North Carolina, United States
NCT00134173
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Fresno, California, United States
NCT00566267
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
NCT00267254
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +5 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States